NCT05788718

An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety

A Multicenter, Prospective, Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety in Non-interventional, Real-world Setting

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 6,458 (actual)
• Sponsor: Boryung Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this observational study is to evaluate patients who are planning to administer sugammadex after rocuronium or vecuronium is used. The main questions it aims to answer are: 1. Prescription pattern of sugammadex 2. Effectiveness and safety of sugammadex Since this study is observational, only data generated under daily treatment are to be collected, and no additional tests or drug administration is conducted for the study. The patients are observed from baseline to 24 hours after the initial administration of sugammadex.

Conditions

• Postoperative Complications
• Neuromuscular Blockade
• Anesthesia

Interventions

Type	Name	Description
DRUG	Sugammadex	As this is a non-interventional study designed to collect data as part of routine clinical practice, the type and dose of neuromuscular blocking agents are all based on the clinician's judgment.

Timeline

• Start date: 2023-04-11
• Primary completion: 2025-05-08
• Completion: 2025-05-08
• First posted: 2023-03-29
• Last updated: 2026-04-13

Locations

1 site across 1 country: South Korea